ERBB2 and neoplasm: To assess the clinical course of the disease and to make decisions about treatment, factors such as tumour stage, tumour grade, oestrogen receptor (ER) and progesterone receptor (PR) status and expression of the human epidermal growth factor receptor (HER2) are considered.